Form 4: Rigel Pharmaceuticals CEO Exercises Stock Options and Sells Shares
SEC Form 4 Filing
Rigel Pharmaceuticals CEO, Raul R. Rodriguez, exercised stock options and sold shares on January 24, 2025, according to a recent SEC filing.
Summary
- Raul R. Rodriguez, CEO and President of Rigel Pharmaceuticals, executed multiple transactions involving the company's stock on January 24, 2025.
- He exercised stock options to acquire 45,000 shares of common stock at a price of $21.40 per share.
- Simultaneously, he sold 44,078 shares of common stock at a price of $22.17 per share.
- These transactions resulted in a net change in his holdings, with a final total of 206,506 shares of common stock directly owned.
- The reported transactions also include adjustments for a one-for-ten reverse stock split that occurred on June 27, 2024.
Sentiment
Score: 5
Explanation: The document is a neutral report of insider trading activity. It doesn't indicate positive or negative sentiment about the company's performance.
Industry Context
This filing is a routine disclosure of insider transactions, which is common in the pharmaceutical industry. It provides transparency into the trading activities of company executives.
Comparison to Industry Standards
- SEC Form 4 filings are standard practice for publicly traded companies, including those in the pharmaceutical sector like Rigel.
- Similar filings are made by executives at companies like Gilead Sciences, Amgen, and Biogen when they engage in stock transactions.
- The level of detail and the type of information disclosed in this filing are consistent with regulatory requirements and industry norms.
Stakeholder Impact
- The transactions may have a minor impact on the stock price, but are generally considered routine.
- Shareholders may be interested in the trading activity of the CEO as an indicator of management's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 01/01/2015 | Start date for the vesting of the employee stock options. |
| 04/04/2016 | Date of the employee stock option grant. |
| 06/27/2024 | Effective date of the one-for-ten reverse stock split. |
| 01/24/2025 | Date of the stock option exercise and share sale transactions. |
| 01/26/2025 | Expiration date of the employee stock options. |
| 01/28/2025 | Date the SEC Form 4 was signed. |
Keywords
SEC Form 4, Rigel Pharmaceuticals, Stock Options, Insider Trading, Raul R. Rodriguez, Share Transactions, Reverse Stock Split
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.